Company Filing History:
Years Active: 2019
Title: Mark Turner - Innovator in Oligonucleotide Therapeutics
Introduction
Mark Turner is a notable inventor based in Hoersholm, Denmark. He has made significant contributions to the field of oligonucleotide therapeutics, particularly through his innovative work on poly oligomer compounds.
Latest Patents
Mark Turner holds a patent for a poly oligomer compound with biocleavable conjugates. This invention focuses on poly oligo oligonucleotide conjugates, where two or more antisense oligonucleotides are covalently linked by physiologically labile linkers. The patent also includes a biocleavable functional group, enhancing the therapeutic potential of these compounds.
Career Highlights
Mark is currently employed at Hoffmann-La Roche Inc., a leading global healthcare company. His work at this esteemed organization has allowed him to further his research and development in the field of biopharmaceuticals.
Collaborations
Throughout his career, Mark has collaborated with talented individuals such as Nanna Albaek and Henrik Frydenlund Hansen. These partnerships have contributed to the advancement of his research and the successful development of innovative therapeutic solutions.
Conclusion
Mark Turner is a distinguished inventor whose work in oligonucleotide therapeutics has the potential to impact the medical field significantly. His innovative approach to poly oligomer compounds showcases the importance of research and collaboration in advancing healthcare solutions.